USPTO serial 79188981
EUDRATEC
Reviewed by CopyMark Law Group
Reg. 5225267Status 404
- Filing date
- Status date
- Registration date
- Jun 20, 2017
- Examiner
- MANOR, THOMAS M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with EUDRATEC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry, science and photography; Chemicals for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; chemical auxiliaries and intermediate products for the manufacture of pharmaceutical and cosmetic products; unprocessed artificial resins; unprocessed plastics; unprocessed artificial resins in the form of powders, granules, solutions, emulsions, dispersions, and pastes, in particular for use as auxiliaries for the manufacture of pharmaceutical products; biodegradable polymers for the manufacture of medical and pharmaceutical products; acrylic polymers for the manufacture of medical and pharmaceutical products; Chemicals for use in industry, namely, polymethyl methacrylate; Chemicals for use in industry, namely, lactides; Chemicals for use in industry, namely, glycolides; Chemicals for use in industry, namely, dioxanones; Chemicals for use in industry, namely, trimethylene carbonates; Chemicals for use in industry, namely, caprolactones; chemical substances for preserving foodstuffs | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical and veterinary preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Medical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; adjuvants for medical purposes; Drug delivery agents in the nature of coatings, lacquers and glazes for pharmaceutical and veterinary preparations; Delivery agents in the nature of coatings, lacquers and glazes for dietetic substances; chemical preparations for medical, pharmaceutical, veterinary and hygienic purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; esters for pharmaceutical purposes; diagnostic preparations for medical purposes; medicated gum and gamboge for medical purposes; chemico-pharmaceutical preparations, namely, drug delivery agents in the form of a coating in granule, powder, aqueous solution and organic solution form to facilitate the delivery of a wide range of pharmaceuticals; surgical implants grown from living cells; capsules for medical purposes, namely, drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents consisting of compounds and coatings that facilitate modified release, sustained release and delayed released delivery of a wide range of pharmaceuticals; Disinfectants in the nature of hygienic preparations and articles; Disinfectants in the nature of hygienic preparations for medical purposes; dietetic food and substances, namely, pasta, and crackers adapted for medical or veterinary use; dietetic preparations, namely, pasta, and crackers; and nutritional supplements; drug delivery agents adapted for medical use, namely, coatings for use as an integral component of pharmaceuticals for the protection of pills and suppositories; food for babies; Medical and surgical plasters; materials for medical dressings, namely, bandages; material for stopping teeth; dental impression materials; disinfectants; preparations for destroying vermin; fungicides; herbicides | SECTION 71 - CANCELLED | — |
| 040 | Treatment of materials, namely, processing and formulation of chemical and pharmaceutical polymers for the manufacture of chemical, pharmaceutical and veterinary preparations; custom manufacture of chemical, pharmaceutical and veterinary compositions by means of microencapsulating techniques for others; treatment of materials, namely, processing and formulation of biodegradable polymers for medical applications, in particular tissue replacement, bone formation and bone fixation as well as for the manufacture of chemical, pharmaceutical and veterinary preparations; treatment of materials, namely, processing and formulation of chemical and pharmaceutical preparations for the controlled release of active ingredients in chemical, pharmaceutical and veterinary preparations; treatment of materials, namely, processing and formulation of chemical and pharmaceutical preparations used for surgical, medical, dental and veterinary apparatus and instruments as well as diagnostic apparatus for medical use and apparatus for use in medical analysis; treatment of materials, namely, processing and formulation of biodegradable polymers for the manufacture of artificial limbs, artificial implants, stents, syringes for medical purposes, catheter, cannula, acupuncture needles, suture needles, artificial limbs, eyes a teeth, medical guidewires, orthopedic articles, suture materials; custom manufacturing of medical products and pharmaceutical coatings and assembly services in the field of pharmaceutical products and medical products | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services and research and design relating thereto in the field of pharmaceuticals, pharmaceutical protection, and pharmaceutical coating; industrial analysis and research services in the field of pharmaceuticals, pharmaceutical protection, and pharmaceutical coating; design and development of computer hardware and software; technical consultancy in the field of the manufacture of chemical, pharmaceutical and veterinary preparations using chemical and pharmaceutical polymers; technical consultancy in the field of the use of biodegradable polymers for medical applications; quality control and material testing; professional consultancy relating to scientific and technological services in the field of pharmaceuticals, pharmaceutical protection, and pharmaceutical coating; materials testing and analysis; chemistry services in the nature of chemistry consultation, and chemistry research; engineering services; bacteriological or chemical laboratory research services; consultancy in the field of physics | SECTION 71 - CANCELLED | — |
| 044 | Medical services in the field of surgery and drug delivery; veterinary services; hygienic and beauty care for human beings or animals; Pharmaceutical services in field of pharmaceutical compounding services | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Evonik Röhm GmbH
- Other trademarks owned by Evonik Operations GmbH
- Other trademarks owned by Evonik Röhm GmbH
- Other trademarks owned by Evonik Röhm GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EUDRATEC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 16, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Sep 29, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 11, 2024 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 11, 2024 | INPC | INVALIDATION PROCESSED | — |
| Sep 6, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 5, 2024 | C71T | CANCELLED SECTION 71 | — |
| Jul 30, 2020 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Oct 28, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 27, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 27, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 20, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 2, 2017 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jul 24, 2017 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jul 14, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 14, 2017 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jul 7, 2017 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jun 20, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 4, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 15, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 15, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 15, 2017 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 27, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 8, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 8, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 8, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 6, 2017 | ALIE | ASSIGNED TO LIE | — |
| Jan 19, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 5, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 20, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 20, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 20, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 19, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 19, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 15, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 15, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 14, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |